At a glance
ClinicalIndex Comparison RecordN/ACompleted· 74 enrolled
Drug / intervention
Arcos Revision Stem Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Arcos Revision Stem: Evaluation of Clinical Performance
In Brief
An observational study evaluating Arcos Revision Stem System for Osteoarthritis and 5 related conditions. Completed, enrolled 74 participants across 5 sites in 4 countries.
Detailed Summary
The primary purpose of this study is to evaluate the clinical performance of the Arcos Revision Stem system, determine the stability of the implants, and evaluate any relationship between Paprosky bone defect level and the success of the Arcos Stem.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Deformity, Fracture, Complications; Arthroplasty
CountriesFinland, Spain, Sweden, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedMar 2013
Primary CompletionJun 2021
TodayJul 2026
First PostedMar 29, 2013
Enrollment StartFeb 1, 2013
Primary CompletionJun 14, 2021
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 13.3 years ago
Interventions
Arcos Revision Stem Systemdevice
Revision Hip System